{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:08:58Z","timestamp":1783462138832,"version":"3.55.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004166","name":"Warszawski Uniwersytet Medyczny","doi-asserted-by":"publisher","award":["1M4\/M\/MB2\/N\/20"],"award-info":[{"award-number":["1M4\/M\/MB2\/N\/20"]}],"id":[{"id":"10.13039\/501100004166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.advms.2023.09.001","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T07:16:41Z","timestamp":1694243801000},"page":"298-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The profile of adipokines associated with fibrosis and impaired microcirculation in systemic sclerosis"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4447-282X","authenticated-orcid":false,"given":"Anna","family":"Niemczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wa\u015bkiel-Burnat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Zaremba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Czuwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Rudnicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.advms.2023.09.001_bib1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/1744666X.2019.1614915","article-title":"Pathophysiology of systemic sclerosis: current understanding and new insights","volume":"15","author":"Cutolo","year":"2019","journal-title":"Expet Rev Clin Immunol"},{"issue":"10103","key":"10.1016\/j.advms.2023.09.001_bib2","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.advms.2023.09.001_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00403-019-01893-1","article-title":"The role of adipokines in systemic sclerosis: a missing link?","volume":"311","author":"\u017b\u00f3\u0142kiewicz","year":"2019","journal-title":"Arch Dermatol Res"},{"issue":"9","key":"10.1016\/j.advms.2023.09.001_bib4","first-page":"789","article-title":"Meta-analysis of circulating adiponectin, leptin, and resistin levels in systemic sclerosis","volume":"76","author":"Lee","year":"2017","journal-title":"Z\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.advms.2023.09.001_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020216","article-title":"Adipokines and autoimmunity in inflammatory arthritis","volume":"10","author":"Neumann","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.advms.2023.09.001_bib6","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s12026-016-8808-8","article-title":"Emerging role of adipokines in systemic lupus erythematosus","volume":"64","author":"Li","year":"2016","journal-title":"Immunol Res"},{"issue":"7","key":"10.1016\/j.advms.2023.09.001_bib7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.tips.2015.04.014","article-title":"Adipokines in health and disease","volume":"36","author":"Fasshauer","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.advms.2023.09.001_bib8","first-page":"251","volume":"vol. 311","author":"\u017b\u00f3\u0142kiewicz","year":"2019"},{"issue":"11","key":"10.1016\/j.advms.2023.09.001_bib9","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.tem.2010.08.001","article-title":"Chemerin: at the crossroads of inflammation and obesity","volume":"21","author":"Ernst","year":"2010","journal-title":"Trends Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.advms.2023.09.001_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/iub.1242","article-title":"Processing, signaling, and physiological function of chemerin","volume":"66","author":"Mattern","year":"2014","journal-title":"IUBMB Life"},{"issue":"9","key":"10.1016\/j.advms.2023.09.001_bib11","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1182\/blood-2006-08-038844","article-title":"The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues","volume":"109","author":"Parolini","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.advms.2023.09.001_bib12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.5114\/ada.2018.79104","article-title":"Visfatin and chemerin levels correspond with inflammation and might reflect the bridge between metabolism, inflammation and fibrosis in patients with systemic sclerosis","volume":"36","author":"Sawicka","year":"2019","journal-title":"Postepy Dermatol Alergol"},{"issue":"1","key":"10.1016\/j.advms.2023.09.001_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.yexmp.2011.10.006","article-title":"Chemerin induces CCL2 and TLR4 in synovial fibroblasts of patients with rheumatoid arthritis and osteoarthritis","volume":"92","author":"Eisinger","year":"2012","journal-title":"Exp Mol Pathol"},{"issue":"2","key":"10.1016\/j.advms.2023.09.001_bib14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.advms.2021.05.002","article-title":"Chemerin activity in selected pathological states of human body - a systematic review","volume":"66","author":"Acewicz","year":"2021","journal-title":"Adv Med Sci"},{"issue":"1","key":"10.1016\/j.advms.2023.09.001_bib15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.yexmp.2011.10.006","article-title":"Chemerin induces CCL2 and TLR4 in synovial fibroblasts of patients with rheumatoid arthritis and osteoarthritis","volume":"92","author":"Eisinger","year":"2012","journal-title":"Exp Mol Pathol"},{"issue":"4","key":"10.1016\/j.advms.2023.09.001_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/14712598.2019.1575358","article-title":"Complement inhibition as a therapeutic strategy in retinal disorders","volume":"19","author":"Kassa","year":"2019","journal-title":"Expet Opin Biol Ther"},{"key":"10.1016\/j.advms.2023.09.001_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.712572","article-title":"Complement factor D as a strategic target for regulating the alternative complement pathway","volume":"12","author":"Barratt","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.advms.2023.09.001_bib18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12876-021-01721-9","article-title":"Association of circulating adipsin with nonalcoholic fatty liver disease in obese adults: a cross-sectional study","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Gastroenterol"},{"issue":"10","key":"10.1016\/j.advms.2023.09.001_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.05.032","article-title":"Fat-produced adipsin regulates inflammatory arthritis","volume":"27","author":"Li","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.advms.2023.09.001_bib20","article-title":"Adipsin of the alternative complement pathway is a potential predictor for preeclampsia in early pregnancy","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.advms.2023.09.001_bib21","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1373\/clinchem.2018.287581","article-title":"Complement C3 and risk of diabetic microvascular disease: a cohort study of 95202 individuals from the general population","volume":"64","author":"Rasmussen","year":"2018","journal-title":"Clin Chem"},{"key":"10.1016\/j.advms.2023.09.001_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113856","article-title":"Retinol binding protein 4 antagonists and protein synthesis inhibitors: potential for therapeutic development","volume":"226","author":"Kim","year":"2021","journal-title":"Eur J Med Chem"},{"issue":"6","key":"10.1016\/j.advms.2023.09.001_bib23","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3945\/an.115.008292","article-title":"Retinol binding protein 4 in relation to diet, inflammation, immunity, and cardiovascular diseases","volume":"6","author":"Zabetian-Targhi","year":"2015","journal-title":"Adv Nutr"},{"key":"10.1016\/j.advms.2023.09.001_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/CEG.S229689","article-title":"The utility of retinol-binding protein 4 in predicting liver fibrosis in chronic hepatitis C patients in response to direct-acting antivirals","volume":"13","author":"Fayed","year":"2020","journal-title":"Clin Exp Gastroenterol"},{"issue":"3","key":"10.1016\/j.advms.2023.09.001_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12030623","article-title":"Retinol-binding protein 4 accelerates metastatic spread and increases impairment of blood flow in mouse mammary gland tumors","volume":"12","author":"Papiernik","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.advms.2023.09.001_bib26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cca.2018.05.012","article-title":"Review: apelin in disease","volume":"483","author":"Antushevich","year":"2018","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.advms.2023.09.001_bib27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.regpep.2003.11.002","article-title":"Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells","volume":"118","author":"Kleinz","year":"2004","journal-title":"Regul Pept"},{"key":"10.1016\/j.advms.2023.09.001_bib28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pharmthera.2018.05.013","article-title":"Vascular effects of apelin: mechanisms and therapeutic potential","volume":"190","author":"Mughal","year":"2018","journal-title":"Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.advms.2023.09.001_bib29","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1210\/en.2010-0754","article-title":"Apelin mediates the induction of profibrogenic genes in human hepatic stellate cells","volume":"151","author":"Melgar-Lesmes","year":"2010","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.advms.2023.09.001_bib30","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/HJH.0b013e32834347de","article-title":"Apelin protects against angiotensin II-induced cardiovascular fibrosis and decreases plasminogen activator inhibitor type-1 production","volume":"29","author":"Siddiquee","year":"2011","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.advms.2023.09.001_bib31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cca.2016.02.025","article-title":"The apelin-APJ axis: a novel potential therapeutic target for organ fibrosis","volume":"456","author":"Huang","year":"2016","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.advms.2023.09.001_bib32","first-page":"9","article-title":"Visfatin--a review","volume":"15","author":"Sonoli","year":"2011","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.advms.2023.09.001_bib33","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.4049\/jimmunol.178.3.1748","article-title":"Visfatin, an adipocytokine with proinflammatory and immunomodulating properties","volume":"178","author":"Moschen","year":"2007","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.advms.2023.09.001_bib34","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00441-014-1997-3","article-title":"The role of visfatin on the regulation of inflammation and apoptosis in the spleen of LPS-treated rats","volume":"359","author":"Xiao","year":"2015","journal-title":"Cell Tissue Res"},{"issue":"7","key":"10.1016\/j.advms.2023.09.001_bib35","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/14728222.2019.1617274","article-title":"Visfatin as a therapeutic target for rheumatoid arthritis","volume":"23","author":"Franco-Trepat","year":"2019","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"10.1016\/j.advms.2023.09.001_bib36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10753-011-9328-2","article-title":"Visfatin levels in Behcet's disease","volume":"35","author":"Sezen","year":"2012","journal-title":"Inflammation"},{"issue":"3","key":"10.1016\/j.advms.2023.09.001_bib37","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15403\/jgld-3504","article-title":"Serum visfatin as a diagnostic marker of active inflammatory bowel disease","volume":"30","author":"Saadoun","year":"2021","journal-title":"J\u00a0Gastrointestin Liver Dis"},{"issue":"9","key":"10.1016\/j.advms.2023.09.001_bib38","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1111\/jgh.15465","article-title":"Visfatin exacerbates hepatic inflammation and fibrosis in a methionine-choline-deficient diet mouse model","volume":"36","author":"Heo","year":"2021","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.advms.2023.09.001_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155193","article-title":"The up-regulation of markers of adipose tissue fibrosis by visfatin in pre-adipocytes as well as obese children and adolescents","volume":"134","author":"Ezzati-Mobaser","year":"2020","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.advms.2023.09.001_bib40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2174\/138161209787185814","article-title":"Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases","volume":"15","author":"Imai","year":"2009","journal-title":"Curr Pharmaceut Des"},{"issue":"Suppl 3","key":"10.1016\/j.advms.2023.09.001_bib41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/dom.12171","article-title":"The importance of NAMPT\/NAD\/SIRT1 in the systemic regulation of metabolism and ageing","volume":"15","author":"Imai","year":"2013","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.advms.2023.09.001_bib42","doi-asserted-by":"crossref","unstructured":"Watanabe T, Watanabe-Kominato K, Takahashi Y, Kojima M, Watanabe R. Adipose tissue-derived omentin-1 function and regulation. Compr Physiol. p. 765-781.","DOI":"10.1002\/cphy.c160043"},{"key":"10.1016\/j.advms.2023.09.001_bib43","first-page":"118","article-title":"Decreased levels of serum omentin-1 in patients with inflammatory bowel disease","volume":"21","author":"Yin","year":"2015","journal-title":"Med Sci Mon Int Med J Exp Clin Res"},{"issue":"3","key":"10.1016\/j.advms.2023.09.001_bib44","first-page":"379","article-title":"Levels of vaspin and omentin-1 in gingival crevicular fluid as potential markers of inflammation in patients with chronic periodontitis and type 2 diabetes mellitus","volume":"58","author":"Bozkurt Do\u011fan","year":"2016","journal-title":"J\u00a0Oral Sci"},{"issue":"7","key":"10.1016\/j.advms.2023.09.001_bib45","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1136\/ard.2009.119735","article-title":"Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis","volume":"69","author":"Senolt","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.advms.2023.09.001_bib46","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00403-015-1549-z","article-title":"Omentin-1 plasma levels and omentin-1 expression are decreased in psoriatic lesions of psoriasis patients","volume":"307","author":"Zhang","year":"2015","journal-title":"Arch Dermatol Res"},{"issue":"9","key":"10.1016\/j.advms.2023.09.001_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.265","article-title":"Omentin protects against LPS-induced ARDS through suppressing pulmonary inflammation and promoting endothelial barrier via an Akt\/eNOS-dependent mechanism","volume":"7","author":"Qi","year":"2016","journal-title":"Cell Death Dis"},{"issue":"8","key":"10.1016\/j.advms.2023.09.001_bib48","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/oby.2010.351","article-title":"Circulating omentin as a novel biomarker of endothelial dysfunction","volume":"19","author":"Moreno-Navarrete","year":"2011","journal-title":"Obesity"},{"issue":"30","key":"10.1016\/j.advms.2023.09.001_bib49","doi-asserted-by":"crossref","first-page":"10610","DOI":"10.1073\/pnas.0504703102","article-title":"Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity","volume":"102","author":"Hida","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.advms.2023.09.001_bib50","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.diabres.2013.12.002","article-title":"Vaspin inhibited proinflammatory cytokine induced activation of nuclear factor-kappa B and its downstream molecules in human endothelial EA.hy926 cells","volume":"103","author":"Liu","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"10.1016\/j.advms.2023.09.001_bib51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/psc.2621","article-title":"Vaspin (serpinA12) in obesity, insulin resistance, and inflammation","volume":"20","author":"Heiker","year":"2014","journal-title":"J\u00a0Pept Sci"},{"issue":"11","key":"10.1016\/j.advms.2023.09.001_bib52","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"Classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.advms.2023.09.001_bib53","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J\u00a0Rheumatol"},{"issue":"Suppl 3","key":"10.1016\/j.advms.2023.09.001_bib54","article-title":"Role of adipokines in systemic sclerosis pathogenesis","volume":"7","author":"Frommer","year":"2020","journal-title":"Eur J Rheumatol"},{"issue":"6","key":"10.1016\/j.advms.2023.09.001_bib55","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/BOR.0000000000000838","article-title":"Adipose tissue and adipose secretome in systemic sclerosis","volume":"33","author":"Brezovec","year":"2021","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"10.1016\/j.advms.2023.09.001_bib56","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/rheumatology\/keu479","article-title":"Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis","volume":"54","author":"Akamata","year":"2015","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.advms.2023.09.001_bib57","first-page":"223","article-title":"Serum chemerin in systemic sclerosis: a novel marker of early diffuse disease?","volume":"35","author":"Chighizola","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"10.1016\/j.advms.2023.09.001_bib58","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/rheumatology\/kez517","article-title":"Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis","volume":"59","author":"Miyagawa","year":"2020","journal-title":"Rheumatology"},{"issue":"10","key":"10.1016\/j.advms.2023.09.001_bib59","first-page":"2062","article-title":"Brief report: association of elevated adipsin levels with pulmonary arterial hypertension in","volume":"69","author":"Korman","year":"2017","journal-title":"Systemic Sclerosis"},{"issue":"2","key":"10.1016\/j.advms.2023.09.001_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114856","article-title":"The local complement activation on vascular bed of patients with systemic sclerosis: a hypothesis-generating study","volume":"10","author":"Scambi","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.advms.2023.09.001_bib61","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1468-3083.2011.04413.x","article-title":"Clinical significance of serum retinol binding protein-4 levels in patients with systemic sclerosis","volume":"27","author":"Toyama","year":"2013","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"25","key":"10.1016\/j.advms.2023.09.001_bib62","doi-asserted-by":"crossref","first-page":"18265","DOI":"10.1074\/jbc.M606352200","article-title":"Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2","volume":"282","author":"Taylor","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.advms.2023.09.001_bib63","first-page":"37","volume":"vol. 27","author":"Aozasa","year":"2013"},{"key":"10.1016\/j.advms.2023.09.001_bib64","first-page":"1661","volume":"vol. 70","author":"Yokoyama","year":"2018"},{"issue":"7","key":"10.1016\/j.advms.2023.09.001_bib65","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/rheumatology\/ket010","article-title":"A\u00a0possible contribution of visfatin to the resolution of skin sclerosis in patients with diffuse cutaneous systemic sclerosis via a direct anti-fibrotic effect on dermal fibroblasts and Th1 polarization of the immune response","volume":"52","author":"Masui","year":"2013","journal-title":"Rheumatology"},{"issue":"11","key":"10.1016\/j.advms.2023.09.001_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027299","article-title":"Visfatin impairs endothelium-dependent relaxation in rat and human mesenteric microvessels through nicotinamide phosphoribosyltransferase activity","volume":"6","author":"Vallejo","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.advms.2023.09.001_bib67","first-page":"461","volume":"vol. 42","author":"Miura","year":"2015"},{"issue":"1","key":"10.1016\/j.advms.2023.09.001_bib68","first-page":"35","article-title":"Serum adiponectin and vaspin levels in systemic sclerosis","volume":"36","author":"Ozgen","year":"2011","journal-title":"Turk J Biochem"},{"issue":"5","key":"10.1016\/j.advms.2023.09.001_bib69","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/1346-8138.12810","article-title":"Serum vaspin levels: a possible correlation with digital ulcers in patients with systemic sclerosis","volume":"42","author":"Miura","year":"2015","journal-title":"J\u00a0Dermatol"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112623000287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112623000287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:44:13Z","timestamp":1761824653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112623000287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1896112623000287"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2023.09.001","relation":{},"ISSN":["1896-1126"],"issn-type":[{"value":"1896-1126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The profile of adipokines associated with fibrosis and impaired microcirculation in systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2023.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of Medical University of Bialystok.","name":"copyright","label":"Copyright"}]}}